Delivery Order SPE2DB25D3002-SPE2DB25FLQRD
Award Date
5/16/25
Potential Completion Date
5/19/25
Potential Value
$2.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Insulin Aspart 100 Unit/mL Vial 10mL, a critical diabetes medication. The total ceiling value of the contract is $1,809.60, with a period of performance through January 30, 2025. The contract was awarded on a firm-fixed price basis without any set-aside designation, indicating open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,743,151 units of Insulin Aspart 100 Unit/mL in 10 mL vials, with a ceiling value of $4,266.02. The contract has a firm fixed price pricing type and an ultimate completion date of May 30, 2024. The contract is not designated as a set-aside....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Insulin Aspart 100 Unit/mL Vial 10mL, a critical pharmaceutical product, to support military healthcare needs. The contract has a ceiling value of $3,417.48 and a period of performance through January 24, 2024. The contract is a firm-fixed-price delivery order, and there is no set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,463.20 fixed-price delivery order is for the supply of 4568200468 Insulin Aspart 100 Unit/mL Vials (10mL), with a performance period ending on May 12, 2025. The award is not associated with a set-aside program and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4564617692 units of Insulin Aspart 100 Unit/mL Vial 10mL. The award is a Firm Fixed Price contract with a ceiling value of $11,209.30 and a performance period ending on May 16, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a $1,499.50 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Insulin Aspart 100 Unit/mL Vial 10mL. The contract has an ultimate completion date of April 2, 2025 and is not associated with a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $2,822.60, is for the delivery of Insulin Aspart 100 Unit/ML Vials 10ML to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $10,637.56 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,298,990 units of Insulin Aspart 100 Unit/mL pen 3mL. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC allows the DLA to efficiently procure a...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,562.72 fixed-price contract is for the provision of Insulin Aspart 100 Unit/mL 10mL vials, with a performance period ending on May 24, 2024. Amerisourcebergen, a major pharmaceutical distributor, has an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with DLA Troop Support Medical, which serves as the primary vehicle for the...
The Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $2,271.15 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Insulin Aspart 100 Unit/mL vials. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a...